Copiktra (duvelisib) is a type of cancer treatment for certain people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). CLL and SLL are slow-growing cancers that affect a ...

This year’s most-read articles on chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) explored treatment adherence patterns, patient symptom assessment, research on treatment ...

Eli Lilly and Company (NYSE:LLY) is one of the high growth stocks to buy right now. On June 14, Eli Lilly announced positive ...

The Jaypirca application moves to the EC for a decision, expected within the next one to two months.

CAR T-cell therapy positively benefitted patients with patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Breyanzi (lisocabtagene maraleucel), ...

Lorna Warwick, CEO of the Lymphoma Coalition, highlights findings underscoring the vital role of clinician communication in managing adverse effects and supporting patient confidence in lymphoma and ...

Curis plans to dose the initial five patients by the end of July 2026, with data anticipated in December 2026.

How Will I Get Imbruvica? Imbruvica is taken as a tablet, capsule, or liquid suspension that you swallow. The typical dosage is 420 milligrams of Imbruvica once a day. You should take your dose around ...

Leukemia and lymphoma are cancers that affect white blood cells. They are separate conditions, but in some people, they can occur simultaneously. It is possible, but very rare, to have both leukemia ...

Cash position -- $15 million in cash and cash equivalents as of March 31, 2026, with potential for up to $20.2 million in additional gross proceeds upon exercise of PIPE Series B warrants, triggered ...